Form 4 for CUE Cue Biopharma, Inc.
Accepted 2022-08-23 00:00:00 ET · period of report 2022-08-21 · accession 0001209191-22-047161 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-23 | 2022-08-21 | CUE | Millar Kerri-Ann | CFO | M - OptEx | — | +6,667 | 17.1K | +64% | — |
| D | 2022-08-23 | 2022-08-22 | CUE | Millar Kerri-Ann | CFO | F - Tax | $3.05 | -2,828 | 14.3K | -17% | -$8,625 |
| D | 2022-08-23 | 2022-08-21 | CUE | Millar Kerri-Ann | CFO | M - OptEx | $0.00 | -6,667 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-21 | M | A | 6,667 | — | 17,139 | D | — | — | (F1) Represents shares of common stock received upon vesting of a restricted stock unit award |
| 2 | Common | Common Stock | 2022-08-22 | F | D | 2,828 | $3.05 | 14,311 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2022-08-21 | M | D | 6,667 | $0.00 | 0 | D | — · — to — | 6,667 Common Stock | (F2) Each restricted stock unit award represents a contingent right to receive one share of common stock. (F3) Represents a restricted stock unit award granted on August 21, 2020. The restricted stock units vest in three equal annual installments beginning on August 21, 2020. |